Conversational AI platform RevelAi Health has closed on a $3.1 million seed funding round from Ulu Ventures and Symphonic Capital, with participation from Orthopedic VC, Sand Hill Angels and a consortium of orthopedic surgeons.
The AI platform, specifically built for musculoskeletal care, is led by co-founders Hadi Javeed and orthopedic trauma surgeon Christian Pean, MD, according to a June 18 news release.
Currently, healthcare spending on musculoskeletal disorders exceeds $420 billion annually, and the U.S. faces a projected shortage of up to 86,000 physicians by 2036.
RevelAi offers a 24/7 care option for patients, answering patient calls with evidence-based triage, collecting mandated quality reporting questionnaires by voice or text, and converting phone, video and in-person encounters into a structured note with clinical documentation codes and automated risk flags.
From there, clinical content and decision logic are continuously refined by RevelAi’s advisory group of board-certified orthopedic surgeons.
The seed funding will be used to improve EHR and practice-management integrations, expand the company’s library of AI-collected outcome surveys and risk pathways, grow engineering and research teams and accelerate collaborations with health systems, specialty societies and ASC networks, according to the release.
